🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Arkanzas

Kliničke studije za Немалоклетни карцином плућа u državi Arkanzas

34 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u državi Arkanzas.

Gradovi u državi Arkanzas

Zvanični tekst studije (na engleskom)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

BostonGene and Exigent Genomic INsight Study

  • Highlands Oncology Group, Rogers
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06272864

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060), Little Rock
  • Highlands Oncology Group-Research Department ( Site 0062), Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06312137

A Study of DS-3939a in Participants With Solid Tumors

  • Highlands Oncology Group (Hog) - Fayetteville, Fayetteville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07739966

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  • Highlands Oncology Group, PA, Fayetteville
  • St. Bernards Medical Center, Jonesboro
  • St. Bernards Medical Center - Paragould, Paragould
  • и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07144280

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  • Highlands Oncology Group, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06890598

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Mercy Hospital Fort Smith, Fort Smith
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Highlands Oncology Group, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • Mercy Hospital Fort Smith, Fort Smith
  • CARTI Cancer Center, Little Rock
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT03191149

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07293247

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

  • Genesis Cancer and Blood Institute, Hot Springs
  • Highlands Oncology Group, Springdale
Тражи се учесникФаза 3
Узраст од 18 до 90 · Оба пола · Ажурирано 2. 11. 2026. · NCT06745908

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • Highlands Oncology Group - Springdale, Springdale
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT04613596

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  • Research Site, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06692738

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

  • CARTI Cancer Center ( Site 0006), Little Rock
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06422143

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

  • Research Site, Little Rock
  • Research Site, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06357533

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

  • Highlands Oncology Group - Springdale, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06875310

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • University of Arkansas for Medical Sciences /ID# 272923, Little Rock
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06568939

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • Research Site, Little Rock
Тражи се учесникФаза 2
Узраст од 18 до 95 · Оба пола · Ажурирано 21. 10. 2026. · NCT05061550

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
  • University of Arkansas for Medical Sciences, Little Rock
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
  • University of Arkansas for Medical Sciences, Little Rock
Тражи се учесникФаза 2
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Highlands Oncology Group, Fayetteville
  • Highlands Oncology Group, Rogers
  • Highlands Oncology Group, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

  • Highlands Oncology Group, PA, Fayetteville
  • Highlands Oncology Group, PA, Rogers
  • Highlands Oncology Group, PA, Springdale
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07227298

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  • Highlands Oncology Group - Springdale /ID# 277132, Springdale
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07155187

Pan-tumor MRD Study

  • CARTI, Little Rock
  • Highlands Oncology Group (HOG), Springdale
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06605404

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

  • Clinical Study Site, Hot Springs
  • Clinical Study Sites, Jonesboro
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06767514

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • University of Arkansas for Medical Sciences, Little Rock
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06500481

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  • University of Arkansas, Little Rock
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT07444814

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Highlands Oncology Group, Fayetteville
  • Highlands Oncology Group, Rogers
  • Highlands Oncology Group, Springdale
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 6. 7. 2026. · NCT04389632

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Mercy Hospital - FTS, Fort Smith
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 29. 6. 2026. · NCT07327489

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
  • University of Arkansas for Medical Sciences, Little Rock
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

GEMINI-NSCLC: NSCLC Biomarker Study

  • Mercy Clinic Oncology - Fort Smith, Fort Smith
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 5. 2. 2026. · NCT05236114

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Little Rock
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.